Biopharma startup Bugworks Research grabs $9 mln Series A
India and Delaware-based Bugworks Research Inc, a biopharma startup, has secured $9 million in Series A financing. The lead investor was University of Tokyo Edge Capital.
15 August 2018•1 min read
